PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 37 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,000 | -20.0% | 5,150 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -99.6% | 5,150 | -99.6% | 0.00% | -100.0% |
| Q3 2015 | $1,417,000 | -39.5% | 1,200,680 | 0.0% | 0.11% | -40.4% |
| Q2 2015 | $2,341,000 | +9.5% | 1,200,680 | 0.0% | 0.18% | +2.9% |
| Q1 2015 | $2,137,000 | -3.3% | 1,200,680 | 0.0% | 0.17% | -10.8% |
| Q4 2014 | $2,209,000 | -24.0% | 1,200,680 | 0.0% | 0.19% | -3.0% |
| Q3 2014 | $2,906,000 | -4.8% | 1,200,680 | +43.6% | 0.20% | -18.0% |
| Q2 2014 | $3,052,000 | -20.3% | 836,078 | 0.0% | 0.24% | -22.3% |
| Q1 2014 | $3,829,000 | -5.5% | 836,078 | -19.7% | 0.31% | -11.8% |
| Q4 2013 | $4,050,000 | -14.1% | 1,041,078 | 0.0% | 0.36% | -17.6% |
| Q3 2013 | $4,716,000 | -12.0% | 1,041,078 | -4.6% | 0.43% | -5.1% |
| Q2 2013 | $5,357,000 | – | 1,091,078 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,178,440 | $5,338,000 | 5.83% |
| GREAT POINT PARTNERS LLC | 399,007 | $1,808,000 | 1.25% |
| Camber Capital Management LP | 1,790,000 | $8,109,000 | 0.85% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,041,078 | $4,716,000 | 0.43% |
| FEDERATED HERMES, INC. | 10,427,472 | $47,237,000 | 0.18% |
| SILVERBACK ASSET MANAGEMENT LLC | 272,200 | $1,233,000 | 0.10% |
| Catalyst Capital Advisors LLC | 30,000 | $136,000 | 0.07% |
| OBERWEIS ASSET MANAGEMENT INC/ | 54,200 | $246,000 | 0.07% |
| Baillie Gifford | 5,548,351 | $25,134,000 | 0.06% |
| Fore Research & Management, LP | 200,000 | $906,000 | 0.06% |